Department of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Center for Research on Health and Priority Diseases, Ministry of Scientific Research and Innovation, Cameroon.
Acta Trop. 2023 May;241:106864. doi: 10.1016/j.actatropica.2023.106864. Epub 2023 Feb 26.
This study aimed at providing an update of SARS-CoV-2 epidemiology in Douala, the most populated and highly heterogeneous town of Cameroon. A hospital-based cross sectional study was conducted from January to September 2022. A questionnaire was used to collect sociodemographic, anthropometric, and clinical data. Retrotranscriptase quantitative polymerase chain reaction was used to detect SARS-CoV-2 in nasopharyngeal samples. Of the 2354 individuals approached, 420 were included. The mean age of patients was 42.3 ± 14.4 years (range 21 - 82). The prevalence of SARS-CoV-2 infection was 8.1%. The risk of infection with SARS-CoV-2 was increased more than seven times in patients aged ≥ 70 years old (aRR = 7.12, p = 0.001), more than six times in married (aRR = 6.60, p = 0.02), more than seven times in those having completed secondary studies (aRR = 7.85, p = 0.02), HIV-positive patients (aRR = 7.64, p < 0.0001) and asthmatic patients (aRR = 7.60, p = 0.003), and more than nine times in those seeking health care regularly (aRR = 9.24, p = 0.001). In contrast, the risk of SARS-CoV-2 infection was reduced by 86% in patients attending Bonassama hospital (aRR = 0.14, p = 0.04), by 93% in patients of blood group B (aRR = 0.07, p = 0.04), and by 95% in COVID-19 vaccinated participants (aRR = 0.05, p = 0.005). There is need for ongoing surveillance of SARS-CoV-2 in Cameroon, given the position and importance of Douala.
本研究旨在提供喀麦隆人口最多且高度异质的城镇杜阿拉的 SARS-CoV-2 流行病学最新情况。这是一项基于医院的横断面研究,于 2022 年 1 月至 9 月进行。使用问卷收集社会人口学、人体测量学和临床数据。使用逆转录定量聚合酶链反应检测鼻咽样本中的 SARS-CoV-2。在接触的 2354 人中,有 420 人被纳入研究。患者的平均年龄为 42.3 ± 14.4 岁(范围 21-82 岁)。SARS-CoV-2 感染的患病率为 8.1%。年龄≥70 岁的患者感染 SARS-CoV-2 的风险增加了七倍以上(调整后的相对风险 [aRR] = 7.12,p = 0.001),已婚患者的风险增加了六倍以上(aRR = 6.60,p = 0.02),完成中学学业的患者的风险增加了七倍以上(aRR = 7.85,p = 0.02),HIV 阳性患者的风险增加了七倍以上(aRR = 7.64,p < 0.0001),哮喘患者的风险增加了七倍以上(aRR = 7.60,p = 0.003),定期寻求医疗保健的患者的风险增加了九倍以上(aRR = 9.24,p = 0.001)。相反,在 Bonassama 医院就诊的患者感染 SARS-CoV-2 的风险降低了 86%(aRR = 0.14,p = 0.04),血型为 B 的患者的风险降低了 93%(aRR = 0.07,p = 0.04),COVID-19 疫苗接种者的风险降低了 95%(aRR = 0.05,p = 0.005)。鉴于杜阿拉的地位和重要性,喀麦隆有必要持续监测 SARS-CoV-2。